In other words, a lung cancer requires an EGFR mutation plus X addition gene mutations or a KRAS mutation plus Y additional gene mutations where Y > X. WT tumors, lacking any driver genes, require still more mutations (i.e., > Y mutations) to generate a malignant phenotype. Here, KRAS is linked to lung cancer.